These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2806132)

  • 21. Concepts and controversies in oesophageal reflux disease: an interactive evaluation of management trends. Proceedings of a symposium from the XIIIth International Congress of Gastroenterology. Rome, September 1988.
    Scand J Gastroenterol Suppl; 1989; 168():1-84. PubMed ID: 2617173
    [No Abstract]   [Full Text] [Related]  

  • 22. Propranolol and haemorrhage due to rupture of oesophageal varices.
    Dobrilla G; de Pretis G
    Hepatogastroenterology; 1984 Dec; 31(6):245-7. PubMed ID: 6394464
    [No Abstract]   [Full Text] [Related]  

  • 23. Campylobacter pylori: Defining a cause of gastritis and peptic ulcer disease. Proceedings from a symposium of the 13th International Congress of Gastroenterology. Rome, 7 September 1988.
    Scand J Gastroenterol Suppl; 1989; 160():1-68. PubMed ID: 2814345
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of propranolol on portal hypertension].
    Kovacević N; Tomić D; Perisić-Savić M; Grbić R
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():62-4. PubMed ID: 18193814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Physiopathological bases of the medical treatment of portal hypertension].
    Cuccurullo F; Seccia G; Porreca E; Guglielmi MD; Mezzetti A; Tomassetti V; Marzio L
    G Clin Med; 1982 Oct; 63(10):737-43. PubMed ID: 7182198
    [No Abstract]   [Full Text] [Related]  

  • 26. Propranolol for portal hypertension.
    Dominguez P
    Lancet; 1981 Jun; 1(8233):1322-3. PubMed ID: 6112641
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevention of variceal bleeding.
    Ozsoylu S; Koçak N
    J Pediatr Gastroenterol Nutr; 1987; 6(4):648-50. PubMed ID: 3430275
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined use of propranolol and nifedipine offers better effects on portal vein nonuniform remodeling in carbon tetrachloride (CCl(4))-induced portal hypertensive rats.
    Zhang ZQ; Shi B; Wu GQ; Qin KR; Jiang ZL; Zhu L
    Eur J Pharmacol; 2009 Jun; 613(1-3):108-13. PubMed ID: 19401196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Beta-adrenergic inhibitors and portal hypertension].
    Lebrec D
    Therapie; 1985; 40(6):403-6. PubMed ID: 2868535
    [No Abstract]   [Full Text] [Related]  

  • 30. [Behavior of blood ammonia, insulin, glucagon, renin and prolactin during propranolol therapy in cirrhosis patients with portal hypertension].
    Mazzone O; Randazzo G; Catalano D; Noè I
    Clin Ter; 1986 Jul; 118(2):109-14. PubMed ID: 3527539
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effects of propranolol in the patient with liver cirrhosis and hemorrhage caused by esophageal varices].
    Esquivel López A; López Fuertes F; Perches Vega A; Salgado-Escobar JL
    Rev Gastroenterol Mex; 1984; 49(4):211-4. PubMed ID: 6335774
    [No Abstract]   [Full Text] [Related]  

  • 32. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The low incidence of bacterial infections could be a protective factor against variceal bleeding per se in hemodynamic responders to propranolol.
    Senzolo M; Cholongitas E; Marelli L; Thalheimer U; Patch D; Burroughs AK
    Am J Gastroenterol; 2006 Oct; 101(10):2436-7. PubMed ID: 17032210
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostaglandin E1 in vascular disease. Symposium of the International Union of Angiology, 15th World Congress. Rome, 19th September 1989. Proceedings.
    Vasa Suppl; 1989; 28():5-60. PubMed ID: 2609243
    [No Abstract]   [Full Text] [Related]  

  • 35. Abstracts of the VI European Congress of Digestive Endoscopy. Rome, September 4-10, 1988.
    Endoscopy; 1988 Sep; 20 Suppl 2():1-105. PubMed ID: 3409838
    [No Abstract]   [Full Text] [Related]  

  • 36. Risk of hepatic encephalopathy in patients taking propranolol for portal hypertension.
    Reding P
    Lancet; 1982 Sep; 2(8297):550. PubMed ID: 6125697
    [No Abstract]   [Full Text] [Related]  

  • 37. Structural biology and molecular recognition. Proceedings of a satellite symposium of the XIII International Biophysics Congress. September 27-29, 1999. Abstracts.
    Indian J Biochem Biophys; 2001; 38(1-2):1-127. PubMed ID: 11675707
    [No Abstract]   [Full Text] [Related]  

  • 38. Proceedings of the international symposium on portal hypertension and digestive organs, Tokyo, 25 February 1989.
    J Gastroenterol Hepatol; 1989; 4 Suppl 1():1-292. PubMed ID: 2577505
    [No Abstract]   [Full Text] [Related]  

  • 39. Prostacyclin, hypertension and atherosclerosis. Proceedings of a symposium of the 4th European Congress of Hypertension. Milan, 23 June 1989.
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():1-188. PubMed ID: 2514649
    [No Abstract]   [Full Text] [Related]  

  • 40. International Symposium on Xenotransplantation. A satellite symposium held in conjunction with the fourth congress of the European Society for Transplantation. November 1, 1989, Barcelona, Spain.
    Transplant Proc; 1990 Jun; 22(3):1055-361. PubMed ID: 2349661
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.